ReviewPharmaceutics2021

Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and Perspective.

Jing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.